查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1769920

移植診斷市場－全球產業分析、規模、佔有率、成長、趨勢及預測（2025-2035）

Transplant Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 265 Pages | 商品交期: 2-10個工作天內

價格

移植診斷市場 - 報告範圍

TMR 的全球移植診斷市場報告研究了過去和當前的成長趨勢及機遇，旨在深入了解 2025 年至 2035 年預測期內的市場指標。該報告提供了 2019 年至 2035 年期間全球移植診斷市場的收入，以 2025 年為基準年，2035 年為預測年。該報告還提供了 2025 年至 2035 年全球移植診斷市場的年複合成長率(CAGR%)。

本報告經過廣泛的調查後編寫。主要研究工作包括分析師對關鍵意見領袖、產業領導者和輿論領袖進行訪談。次要研究則參考了主要參與者的產品資料、年度報告、新聞稿和相關文件，以了解移植診斷市場。

市場概況
2024 年的市場價值 78億美元
2035年的市場價值 172億美元
複合年成長率 7.3%

本報告深入探討了全球移植診斷市場的競爭格局。該報告確定了全球移植診斷市場的主要參與者，並根據不同特徵對每家公司進行了分析。本報告針對全球移植診斷市場參與者的分析涵蓋公司概況、財務狀況、近期發展和 SWOT 分析。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2017年至2031年全球移植診斷市場分析與預測

第5章：關鍵見解

  • 管道分析
  • 關鍵產品/品牌分析
  • 重要併購
  • COVID-19疫情對產業的影響

第6章：全球市場分析與預測：依篩選

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：依篩選，2017 年至 2031 年
    • 移植前診斷
    • 移植後診斷
  • 市場吸引力：透過篩選

第7章：全球市場分析與預測：依技術

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：依技術分類，2017 年至 2031 年
    • 分子檢測
    • 非分子檢測
    • 7.4 市場吸引力：依技術

第8章：全球市場分析與預測：按應用

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：按應用，2017 年至 2031 年
    • 實體器官移植
      • 腎
      • 肝
      • 心
      • 肺
      • 胰臟
      • 小腸
    • 幹細胞移植
  • 市場吸引力：按應用

第9章：全球市場分析與預測：依產品與服務

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：按產品和服務，2017 年至 2031 年
    • 試劑和耗材
    • 儀器
    • 軟體與服務
  • 市場吸引力：按產品和服務

第10章：全球市場分析與預測：依最終用戶

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017 年至 2031 年
    • 醫院及移植中心
    • 研究實驗室
    • 其他
  • 市場吸引力：按最終用戶

第 11 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017年至2031年
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力：按地區

第12章：北美市場分析與預測

第13章：歐洲市場分析與預測

第14章：亞太市場分析與預測

第15章：拉丁美洲市場分析與預測

第16章：中東和非洲市場分析與預測

第 17 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：按公司（2022年）
  • 公司簡介
    • Bio-Rad laboratories, Inc.
    • Qiagen NV
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson and Company
    • Ortho Clinical Diagnostics
    • Immucor, Inc.
    • Illumina, Inc.
    • Siemens Healthineers (Siemens AG)
    • Agilent Technologies
Product Code: TMRGL20225

Transplant Diagnostics Market - Scope of Report

TMR's report on the global transplant diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global transplant diagnostics market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global transplant diagnostics market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the transplant diagnostics market.

Market Snapshot
Market Value in 2024US$ 7.8 Bn
Market Value in 2035US$ 17.2 Bn
CAGR7.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global transplant diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global transplant diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global transplant diagnostics market.

The report delves into the competitive landscape of the global transplant diagnostics market. Key players operating in the global transplant diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global transplant diagnostics market profiled in this report.

Key Questions Answered in Global transplant diagnostics Market Report:

  • What is the sales/revenue generated by transplant diagnostics across all regions during the forecast period?
  • What are the opportunities in the global transplant diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Transplant Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global transplant diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global transplant diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global transplant diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transplant Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Transplant Diagnostics Market Analysis and Forecast, 2017 to 2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Transplant Diagnostics Market Analysis and Forecast, by Screening

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Screening, 2017 to 2031
    • 6.3.1. Pre-transplant Diagnostics
    • 6.3.2. Post-transplant Diagnostics
  • 6.4. Market Attractiveness, by Screening

7. Global Transplant Diagnostics Market Analysis and Forecast, by Technique

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technique, 2017 to 2031
    • 7.3.1. Molecular Assay
    • 7.3.2. Non-molecular Assay
    • 7.3.3. 7.4 Market Attractiveness, by Technique

8. Global Transplant Diagnostics Market Analysis and Forecast, by Application

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017 to 2031
    • 8.3.1. Solid Organ Transplantation
      • 8.3.1.1. Kidney
      • 8.3.1.2. Liver
      • 8.3.1.3. Heart
      • 8.3.1.4. Lungs
      • 8.3.1.5. Pancreas
      • 8.3.1.6. Small Bowel
    • 8.3.2. Stem Cell Transplantation
  • 8.4. Market Attractiveness, by Application

9. Global Transplant Diagnostics Market Analysis and Forecast, by Products & Services

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Products & Services, 2017 to 2031
    • 9.3.1. Reagents & Consumables
    • 9.3.2. Instruments
    • 9.3.3. Software & Services
  • 9.4. Market Attractiveness, by Products & Services

10. Global Transplant Diagnostics Market Analysis and Forecast, by End-user

  • 10.1. Introduction and Definitions
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by End-user, 2017 to 2031
    • 10.3.1. Hospitals & Transplant Centers
    • 10.3.2. Research Laboratories
    • 10.3.3. Others
  • 10.4. Market Attractiveness, by End-user

11. Global Transplant Diagnostics Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2017 to 2031
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness, by Region

12. North America Transplant Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Screening, 2017 to 2031
    • 12.2.1. Pre-transplant Diagnostics
    • 12.2.2. Post-transplant Diagnostics
  • 12.3. Market Attractiveness, by Screening
  • 12.4. Market Value Forecast, by Technique, 2017 to 2031
    • 12.4.1. Molecular Assay
    • 12.4.2. Non-molecular Assay
  • 12.5. Market Attractiveness, by Technique
  • 12.6. Market Value Forecast, by Application, 2017 to 2031
    • 12.6.1. Solid Organ Transplantation
      • 12.6.1.1. Kidney
      • 12.6.1.2. Liver
      • 12.6.1.3. Heart
      • 12.6.1.4. Lungs
      • 12.6.1.5. Pancreas
      • 12.6.1.6. Small Bowel
    • 12.6.2. Stem Cell Transplantation
  • 12.7. Market Attractiveness, by Application
  • 12.8. Market Value Forecast, by Products & Services, 2017 to 2031
    • 12.8.1. Reagents & Consumables
    • 12.8.2. Instruments
    • 12.8.3. Software & Services
  • 12.9. Market Attractiveness, by Products & Services
  • 12.10. Market Value Forecast, by End-user, 2017 to 2031
    • 12.10.1. Hospitals & Transplant Centers
    • 12.10.2. Research Laboratories
    • 12.10.3. Others
  • 12.11. Market Attractiveness, by End-user
  • 12.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
    • 12.12.1. U.S.
    • 12.12.2. Canada
  • 12.13. Market Attractiveness Analysis
    • 12.13.1. By Screening
    • 12.13.2. By Technique
    • 12.13.3. By Application
    • 12.13.4. By Products & Services
    • 12.13.5. By End-user
    • 12.13.6. By Country

13. Europe Transplant Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Screening, 2017 to 2031
    • 13.2.1. Pre-transplant Diagnostics
    • 13.2.2. Post-transplant Diagnostics
  • 13.3. Market Attractiveness, by Screening
  • 13.4. Market Value Forecast, by Technique, 2017 to 2031
    • 13.4.1. Molecular Assay
    • 13.4.2. Non-molecular Assay
  • 13.5. Market Attractiveness, by Technique
  • 13.6. Market Value Forecast, by Application, 2017 to 2031
    • 13.6.1. Solid Organ Transplantation
      • 13.6.1.1. Kidney
      • 13.6.1.2. Liver
      • 13.6.1.3. Heart
      • 13.6.1.4. Lungs
      • 13.6.1.5. Pancreas
      • 13.6.1.6. Small Bowel
    • 13.6.2. Stem Cell Transplantation
  • 13.7. Market Attractiveness, by Application
  • 13.8. Market Value Forecast, by Products & Services, 2017 to 2031
    • 13.8.1. Reagents & Consumables
    • 13.8.2. Instruments
    • 13.8.3. Software & Services
  • 13.9. Market Attractiveness, by Products & Services
  • 13.10. Market Value Forecast, by End-user, 2017 to 2031
    • 13.10.1. Hospitals & Transplant Centers
    • 13.10.2. Research Laboratories
    • 13.10.3. Others
  • 13.11. Market Attractiveness, by End-user
  • 13.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
    • 13.12.1. Germany
    • 13.12.2. U.K.
    • 13.12.3. France
    • 13.12.4. Italy
    • 13.12.5. Spain
    • 13.12.6. Rest of Europe
  • 13.13. Market Attractiveness Analysis
    • 13.13.1. By Screening
    • 13.13.2. By Technique
    • 13.13.3. By Application
    • 13.13.4. By Products & Services
    • 13.13.5. By End-user
    • 13.13.6. By Country/Sub-region

14. Asia Pacific Transplant Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Screening, 2017 to 2031
    • 14.2.1. Pre-transplant Diagnostics
    • 14.2.2. Post-transplant Diagnostics
  • 14.3. Market Attractiveness, by Screening
  • 14.4. Market Value Forecast, by Technique, 2017 to 2031
    • 14.4.1. Molecular Assay
    • 14.4.2. Non-molecular Assay
  • 14.5. Market Attractiveness, by Technique
  • 14.6. Market Value Forecast, by Application, 2017 to 2031
    • 14.6.1. Solid Organ Transplantation
      • 14.6.1.1. Kidney
      • 14.6.1.2. Liver
      • 14.6.1.3. Heart
      • 14.6.1.4. Lungs
      • 14.6.1.5. Pancreas
      • 14.6.1.6. Small Bowel
    • 14.6.2. Stem Cell Transplantation
  • 14.7. Market Attractiveness, by Application
  • 14.8. Market Value Forecast, by Products & Services, 2017 to 2031
    • 14.8.1. Reagents & Consumables
    • 14.8.2. Instruments
    • 14.8.3. Software & Services
  • 14.9. Market Attractiveness, by Products & Services
  • 14.10. Market Value Forecast, by End-user, 2017 to 2031
    • 14.10.1. Hospitals & Transplant Centers
    • 14.10.2. Research Laboratories
    • 14.10.3. Others
  • 14.11. Market Attractiveness, by End-user
  • 14.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
    • 14.12.1. China
    • 14.12.2. Japan
    • 14.12.3. India
    • 14.12.4. Australia & New Zealand
    • 14.12.5. Rest of Asia Pacific
  • 14.13. Market Attractiveness Analysis
    • 14.13.1. By Screening
    • 14.13.2. By Technique
    • 14.13.3. By Application
    • 14.13.4. By Products & Services
    • 14.13.5. By End-user
    • 14.13.6. By Country/Sub-region

15. Latin America Transplant Diagnostics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Screening, 2017 to 2031
    • 15.2.1. Pre-transplant Diagnostics
    • 15.2.2. Post-transplant Diagnostics
  • 15.3. Market Attractiveness, by Screening
  • 15.4. Market Value Forecast, by Technique, 2017 to 2031
    • 15.4.1. Molecular Assay
    • 15.4.2. Non-molecular Assay
  • 15.5. Market Attractiveness, by Technique
  • 15.6. Market Value Forecast, by Application, 2017 to 2031
    • 15.6.1. Solid Organ Transplantation
      • 15.6.1.1. Kidney
      • 15.6.1.2. Liver
      • 15.6.1.3. Heart
      • 15.6.1.4. Lungs
      • 15.6.1.5. Pancreas
      • 15.6.1.6. Small Bowel
    • 15.6.2. Stem Cell Transplantation
  • 15.7. Stem Cell Transplantation Market Attractiveness, by Application
  • 15.8. Market Value Forecast, by Products & Services, 2017 to 2031
    • 15.8.1. Reagents & Consumables
    • 15.8.2. Instruments
    • 15.8.3. Software & Services
  • 15.9. Market Attractiveness, by Products & Services
  • 15.10. Market Value Forecast, by End-user, 2017 to 2031
    • 15.10.1. Hospitals & Transplant Centers
    • 15.10.2. Research Laboratories
    • 15.10.3. Others
  • 15.11. Market Attractiveness, by End-user
  • 15.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
    • 15.12.1. Brazil
    • 15.12.2. Mexico
    • 15.12.3. Rest of Latin America
  • 15.13. Market Attractiveness Analysis
    • 15.13.1. By Screening
    • 15.13.2. By Technique
    • 15.13.3. By Application
    • 15.13.4. By Products & Services
    • 15.13.5. By End-user
    • 15.13.6. By Country/Sub-region

16. Middle East & Africa Transplant Diagnostics Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Screening, 2017 to 2031
    • 16.2.1. Pre-transplant Diagnostics
    • 16.2.2. Post-transplant Diagnostics
  • 16.3. Market Attractiveness, by Screening
  • 16.4. Market Value Forecast, by Technique, 2017 to 2031
    • 16.4.1. Molecular Assay
    • 16.4.2. Non-molecular Assay
  • 16.5. Market Attractiveness, by Technique
  • 16.6. Market Value Forecast, by Application, 2017 to 2031
    • 16.6.1. Solid Organ Transplantation
      • 16.6.1.1. Kidney
      • 16.6.1.2. Liver
      • 16.6.1.3. Heart
      • 16.6.1.4. Lungs
      • 16.6.1.5. Pancreas
      • 16.6.1.6. Small Bowel
    • 16.6.2. Stem Cell Transplantation
  • 16.7. Market Attractiveness, by Application
  • 16.8. Market Value Forecast, by Products & Services, 2017 to 2031
    • 16.8.1. Reagents & Consumables
    • 16.8.2. Instruments
    • 16.8.3. Software & Services
  • 16.9. Market Attractiveness, by Products & Services
  • 16.10. Market Value Forecast, by End-user, 2017 to 2031
    • 16.10.1. Hospitals & Transplant Centers
    • 16.10.2. Research Laboratories
    • 16.10.3. Others
  • 16.11. Market Attractiveness, by End-user
  • 16.12. Market Value Forecast, by Country/Sub-region, 2017 to 2031
    • 16.12.1. GCC Countries
    • 16.12.2. South Africa
    • 16.12.3. Rest of Middle East & Africa
  • 16.13. Market Attractiveness Analysis
    • 16.13.1. By Screening
    • 16.13.2. By Technique
    • 16.13.3. By Application
    • 16.13.4. By Products & Services
    • 16.13.5. By End-user
    • 16.13.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 17.2. Market Share Analysis, by Company (2022)
  • 17.3. Company Profiles
    • 17.3.1. Bio-Rad laboratories, Inc.
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. SWOT Analysis
      • 17.3.1.5. Strategic Overview
    • 17.3.2. Qiagen N.V.
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. SWOT Analysis
      • 17.3.2.5. Strategic Overview
    • 17.3.3. F. Hoffmann-La Roche AG
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. SWOT Analysis
      • 17.3.3.5. Strategic Overview
    • 17.3.4. Thermo Fisher Scientific, Inc.
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. SWOT Analysis
      • 17.3.4.5. Strategic Overview
    • 17.3.5. Becton, Dickinson and Company
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. Financial Overview
      • 17.3.5.4. SWOT Analysis
      • 17.3.5.5. Strategic Overview
    • 17.3.6. Ortho Clinical Diagnostics
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. SWOT Analysis
      • 17.3.6.5. Strategic Overview
    • 17.3.7. Immucor, Inc.
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. SWOT Analysis
      • 17.3.7.5. Strategic Overview
    • 17.3.8. Illumina, Inc.
      • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. Financial Overview
      • 17.3.8.4. SWOT Analysis
      • 17.3.8.5. Strategic Overview
    • 17.3.9. Siemens Healthineers (Siemens AG)
      • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. Financial Overview
      • 17.3.9.4. SWOT Analysis
      • 17.3.9.5. Strategic Overview
    • 17.3.10. Agilent Technologies
      • 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.10.2. Product Portfolio
      • 17.3.10.3. Financial Overview
      • 17.3.10.4. SWOT Analysis
      • 17.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
  • Table 02: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
  • Table 03: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
  • Table 04: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
  • Table 05: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
  • Table 06: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017 to 2031
  • Table 07: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017 to 2031
  • Table 08: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
  • Table 09: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
  • Table 10: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
  • Table 11: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
  • Table 12: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
  • Table 13: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031
  • Table 14: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
  • Table 15: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
  • Table 16: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
  • Table 17: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
  • Table 18: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
  • Table 19: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031
  • Table 20: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
  • Table 21: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
  • Table 22: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
  • Table 23: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
  • Table 24: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
  • Table 25: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031
  • Table 26: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
  • Table 27: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
  • Table 28: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
  • Table 29: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
  • Table 30: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031
  • Table 31: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 to 2031
  • Table 32: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017 to 2031
  • Table 33: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017 to 2031
  • Table 34: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017 to 2031
  • Table 35: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017 to 2031
  • Table 36: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017 to 2031

List of Figures

  • Figure 01: Global Transplant Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
  • Figure 02: Global Transplant Diagnostics Market Revenue (US$ Mn), by Screening, 2022
  • Figure 03: Global Transplant Diagnostics Market Value Share, by Screening, 2022
  • Figure 04: Global Transplant Diagnostics Market Revenue (US$ Mn), by Technique, 2022
  • Figure 05: Global Transplant Diagnostics Market Value Share, by Technique, 2022
  • Figure 06: Global Transplant Diagnostics Market Revenue (US$ Mn), by Application, 2022
  • Figure 07: Global Transplant Diagnostics Market Value Share, by Application, 2022
  • Figure 08: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022
  • Figure 09: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022
  • Figure 10: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022
  • Figure 11: Global Transplant Diagnostics Market Value Share, by End-user, 2022
  • Figure 12: Global Transplant Diagnostics Market Value Share, by Region, 2022
  • Figure 13: Global Transplant Diagnostics Market Value (US$ Mn) Forecast, 2017 to 2031
  • Figure 14: Global Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 15: Global Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
  • Figure 16: Global Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 17: Global Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
  • Figure 18: Global Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 19: Global Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
  • Figure 20: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022
  • Figure 21: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022
  • Figure 22: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022
  • Figure 23: Global Transplant Diagnostics Market Value Share, by End-user, 2022
  • Figure 24: Global Transplant Diagnostics Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 25: Global Transplant Diagnostics Market Attractiveness Analysis, by Region, 2023 to 2031
  • Figure 26: North America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031
  • Figure 27: North America Transplant Diagnostics Market Attractiveness Analysis, by Country, 2023 to 2031
  • Figure 28: North America Transplant Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 29: North America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 30: North America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 31: North America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 32: North America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 33: North America Transplant Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031
  • Figure 34: North America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
  • Figure 35: North America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
  • Figure 36: North America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
  • Figure 37: North America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031
  • Figure 38: North America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031
  • Figure 39: Europe Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031
  • Figure 40: Europe Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031
  • Figure 41: Europe Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 42: Europe Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 43: Europe Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 44: Europe Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 45: Europe Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 46: Europe Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 47: Europe Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
  • Figure 48: Europe Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
  • Figure 49: Europe Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
  • Figure 50: Europe Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031
  • Figure 51: Europe Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031
  • Figure 52: Asia Pacific Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031
  • Figure 53: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031
  • Figure 54: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 55: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 56: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 57: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 58: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 59: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 60: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
  • Figure 61: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
  • Figure 62: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
  • Figure 63: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031
  • Figure 64: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031
  • Figure 65: Latin America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031
  • Figure 66: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031
  • Figure 67: Latin America Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 68: Latin America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 69: Latin America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 70: Latin America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 71: Latin America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 72: Latin America Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 73: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
  • Figure 74: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
  • Figure 75: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
  • Figure 76: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031
  • Figure 77: Latin America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031
  • Figure 78: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017 to 2031
  • Figure 79: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023 to 2031
  • Figure 80: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 81: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
  • Figure 82: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
  • Figure 83: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 84: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
  • Figure 85: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 86: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023 to 2031
  • Figure 87: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023 to 2031
  • Figure 88: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023 to 2031
  • Figure 89: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023 to 2031
  • Figure 90: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023 to 2031